(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 869.57 | 975.78 | -10.88 | 869.57 | 975.78 | -10.88 | 3422.36 | 4055.12 | -15.60 |
| Other Income | 9.94 | 11.76 | -15.48 | 9.94 | 11.76 | -15.48 | 93.62 | 46.70 | 100.47 |
| PBIDT | -514.24 | -89.02 | 477.67 | -514.24 | -89.02 | 477.67 | 97.69 | 537.32 | -81.82 |
| Interest | 29.77 | 24.70 | 20.53 | 29.77 | 24.70 | 20.53 | 106.89 | 100.39 | 6.47 |
| PBDT | 452.67 | -126.66 | -457.39 | 452.67 | -126.66 | -457.39 | -30.79 | 436.93 | -107.05 |
| Depreciation | 25.42 | 25.53 | -0.43 | 25.42 | 25.53 | -0.43 | 103.21 | 99.29 | 3.95 |
| PBT | 427.25 | -152.19 | -380.73 | 427.25 | -152.19 | -380.73 | -134.00 | 337.64 | -139.69 |
| TAX | 139.86 | 1.55 | 8923.23 | 139.86 | 1.55 | 8923.23 | 7.85 | 98.42 | -92.02 |
| Deferred Tax | 57.36 | 1.55 | 3600.65 | 57.36 | 1.55 | 3600.65 | 7.85 | 15.42 | -49.09 |
| PAT | 287.39 | -153.74 | -286.93 | 287.39 | -153.74 | -286.93 | -141.85 | 239.22 | -159.30 |
| Equity | 92.10 | 92.04 | 0.07 | 92.10 | 92.04 | 0.07 | 92.10 | 92.04 | 0.07 |
| PBIDTM(%) | -59.14 | -9.12 | 548.22 | -59.14 | -9.12 | 548.22 | 2.85 | 13.25 | -78.46 |
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1900.90 |
| Dr. Reddys Labs. | 1175.00 |
| Cipla | 1426.20 |
| Lupin | 2193.00 |
| Zydus Lifesciences | 1120.00 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: